Ultragenyx Pharmaceutical reported $678.54M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 532.52M 9.7M
Agios Pharmaceuticals AGIO:US $ 870.01M 105.14M
Alnylam Pharmaceuticals ALNY:US $ 2471.64M 118.04M
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Epizyme EPZM:US $ 228.71M 22.66M
Esperion Therapeutics ESPR:US $ 252.48M 38.34M
Insmed INSM:US $ 674.73M 81.41M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Karyopharm Therapeutics KPTI:US $ 242.45M 34.09M
Kyowa Hakko Kirin 4151:JP Y 523253M 24877M
Macrogenics MGNX:US $ 167.63M 50.57M
Mirati Therapeutics MRTX:US $ 1202.93M 140.19M
Moderna Inc MRNA:US 13.56B 2.79B
Neurocrine Biosciences NBIX:US $ 1019.3M 1.1M
Ptc Therapeutics PTCT:US $ 694.68M 79.33M
Puma Biotechnology PBYI:US $ 114.28M 3.29M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Ultragenyx Pharmaceutical RARE:US $ 678.54M 28.98M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M
Vital Therapies VTL:US $ 115.88M 10.89M
Xoma XOMA:US $ 87.26M 2.35M